Migraine Resource Network is a comprehensive educational initiative for clinicians seeking current and emerging information on migraine headache. Our mission is to provide ongoing medical education that embodies evidence-based scientific data, current treatment strategies, and the insightful knowledge of expert faculty. Our goal is to support your ongoing dedication to optimizing treatment outcomes for your patients.

Skip to content

Migraine Resource Network

You are here: Home Continuing Ed Migraine 101 (Accredited)

You need to be logged in to continue.
Please Log In or Register.

You can no longer receive credit for taking this course

Menses and Migraine: An Expert Interview with Ms. Susan Wysocki, WHNP-BC, FAANP, President and CEO of the National Association of Nurse Practitioners in Women’s Health (NPWH)

Release Date: September 14, 2009
Expiration Date: September 14, 2010

Program Overview

Ms. Susan Wysocki sits down with Migraine Resource Network to discuss the issue of migraine in women. She explores the myths of migraine, especially those associated with menstrual migraine, and provides clinical guidance about headache assessment, patient communications, classification of headache, selection of therapy, goals of treatment, and side effect management. Ms. Wysocki also provides listeners with takeaway clinical pearls for practice.

Target Audience

This activity is designed for physicians, pharmacists, nurse practitioners, advanced practice nurses, nurses, and other allied health professionals with an interest in the management of migraine.

Learning Objectives

After completion of this educational activity, participants will be able to:

  1. Describe the clinical features and coding requirements of both pure and menstrually related migraine

  2. Identify assessment methods that effectively contribute to an accurate diagnosis.

  3. Contrast and compare therapeutic options for both acute and preventative menstrual migraine care

  4. Identify risks associated with various migraine therapies

General Information

This activity is eligible for credit through September 14, 2010. After this date, this activity will expire and no further credit will be awarded.

Expected time to complete this activity as designed: 1 hour

There are no fees for participating in this activity. All participants must complete the Online Activity Evaluation. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates may be printed immediately after successfully completing the online self-assessment and evaluation.

This activity is supported by an educational grant from Endo Pharmaceuticals
Endo Pharmaceuticals

Faculty Biography

Susan J. Wysocki, WHNP-BC, FAANP
President and CEO
National Association of Nurse Practitioners in Women’s Health (NPWH)
Washington, DC

Susan Wysocki is president and CEO of the National Association of Nurse Practitioners in Women's Health (NPWH), based in Washington, DC. She is the editor of Women's Health Care: A Practical Journal for Nurse Practitioners and Clinical Challenges in Women’s Health. She also serves on the editorial boards of the American Journal of Nurse Practitioners, Nurse Practitioner World News, Contraceptive Technology Update, and Dialogues in Contraception.


CME Credit
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Credit

MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1 contact hour(s) of Continuing Education Credit. Universal Activity Number:­­­­­­­­ 827-000-09-238-H01-P Knowledge-based CPE activity.

Nursing Credit
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.0 contact hour.
Program Number: 09-238-230

NPWH Credit
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.0 contact hour of continuing education credit. NPWH Activity number 09-19.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly, the following disclosures were made.

Faculty Disclosures

The presenting faculty reported the following: Ms. Susan Wysocki has received honoraria related to formal advisory activities from Bayer AG, Biogen Idec, Boehringer Ingelheim Corporation, Duramed Pharmaceuticals, Inc. (now Teva Pharmaceuticals Industries Ltd), Endo Pharmaceuticals, Eli Lilly and Company, PharmaDerm, a division of Nycomed US Inc., Ortho Women's Health, Upsher-Smith Laboratories, Inc., and Wyeth. She has received honoraria related to speakers’ bureau activities from Bayer, Duramed (now Teva), Organon (now Schering-Plough Corporation), Ther-Rx Corporation, Upsher-Smith, and Wyeth.

Provider Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, executive director; Norma Jean Talley, manager, professional education; and Ruth Widmer, medical editor, have nothing to disclose.

Off-Label/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Ms. Wysocki indicated that her presentation would not include the discussion of unlabeled uses of commercial products or investigational/unapproved products not yet approved by the FDA for any use in the United States.

Conflict of Interest Resolution

To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

Americans with Disabilities Act/Special Needs

MediCom Worldwide, Inc. is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veterans status, or sexual orientation.

Hardware/Software Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, or Windows Media® Player.

©2009 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067.

You need to be logged in to continue.
Please Log In or Register.